Corbus Pharma (CRBP) Advances to Session High, Up 33%

October 5, 2016 11:36 AM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Corbus Pharma (NASDAQ: CRBP) hit session highs heading into mid-day, extending gains after Cantor initiated coverage on the stock with a Buy rating and a price target of $17.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Trader Talk

Add Your Comment